TMDX (STOCKS)
TransMedics Group, Inc. Common Stock
$88.870000
+1.850000 (+2.13%)
Prev close: $87.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Waleed H. Hassanein
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,316.77M
- Employees
- 728
- P/E (TTM)
- 22.64
- P/B (TTM)
- 5.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.44 | $0.48 | -0.0428 | -8.87% |
|
Mar 2026 (Q1)
|
$0.30 | $0.63 | -0.3250 | -52.00% |
|
Dec 2025 (Q4)
|
$0.53 | $0.40 | +0.1313 | +32.93% |
|
Sep 2025 (Q3)
|
$0.66 | $0.36 | +0.3021 | +84.41% |
Financial Statements
| Revenues | $668.47M |
| Benefits Costs and Expenses | $595.91M |
| Cost Of Revenue | $276.12M |
| Costs And Expenses | $595.91M |
| Gross Profit | $392.35M |
| Nonoperating Income/Loss | -$9.05M |
| Operating Expenses | $310.74M |
| Selling, General, and Administrative Expenses | $218.27M |
| Research and Development | $92.47M |
| Operating Income/Loss | $81.61M |
| Income/Loss From Continuing Operations After Tax | $151.70M |
| Income/Loss From Continuing Operations Before Tax | $72.55M |
| Income Tax Expense/Benefit | -$79.15M |
| Net Income/Loss | $151.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $151.70M |
| Net Income/Loss Available To Common Stockholders, Basic | $151.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $4.45 |
| Diluted Earnings Per Share | $3.86 |
| Basic Average Shares | 68,671,548 |
| Diluted Average Shares | 76,882,186 |
| Assets | $1.46B |
| Current Assets | $651.12M |
| Inventory | $54.14M |
| Other Current Assets | $596.99M |
| Noncurrent Assets | $813.27M |
| Fixed Assets | $365.30M |
| Intangible Assets | $0.00 |
| Other Non-current Assets | $447.97M |
| Liabilities | $946.34M |
| Current Liabilities | $98.28M |
| Accounts Payable | $12.91M |
| Wages | $20.22M |
| Other Current Liabilities | $65.15M |
| Noncurrent Liabilities | $848.06M |
| Equity | $518.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $518.05M |
| Liabilities And Equity | $1.46B |
| Net Cash Flow From Operating Activities | $145.93M |
| Net Cash Flow From Operating Activities, Continuing | $145.93M |
| Net Cash Flow From Investing Activities | -$66.89M |
| Net Cash Flow From Investing Activities, Continuing | -$66.89M |
| Net Cash Flow From Financing Activities | $11.47M |
| Net Cash Flow From Financing Activities, Continuing | $11.47M |
| Exchange Gains/Losses | -$475.00K |
| Net Cash Flow | $90.04M |
| Net Cash Flow, Continuing | $90.51M |
| Comprehensive Income/Loss | $151.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $151.39M |
| Other Comprehensive Income/Loss | -$308.00K |